[Federal Register Volume 69, Number 95 (Monday, May 17, 2004)]
[Notices]
[Page 27928]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-11033]



[[Page 27928]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Meeting of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (DHHS) is hereby giving notice 
that the National Vaccine Advisory Committee (NVAC) will hold a 
meeting. The meeting is open to the public.

DATES: The meeting will be held on June 1, 2004, from 9 am to 3:30 pm, 
and on June 2, 2004, from 9 am to 3:15 pm.

ADDRESSES: Department of Health and Human Services, Hubert H. Humphrey 
Building, 200 Independence Avenue, Room 705A, SW., Washington, DC 
20201.

FOR FURTHER INFORMATION, CONTACT: Ms. Emma English, Program Analyst, 
National Vaccine Program Office, Department of Health and Human 
Services, Hubert H. Humphrey Building, 200 Independence Avenue, Room 
725H, SW., Washington, DC 20201; (202) 690-5566.

SUPPLEMENTARY INFORMATION: Pursuant to section 2101 of the Public 
Service Act (42 U.S.C. 300aa-1), the Secretary of Health and Human 
Services was mandated to establish the National Vaccine Program (NVP) 
to achieve optimal prevention of human infectious diseases through 
immunization and to achieve optimal prevention against adverse 
reactions to vaccines. The Secretary designated the Assistant Secretary 
for Health to serve as the Director, NVP. The National Vaccine Advisory 
Committee (NVAC) was established to provide advice and make 
recommendations to the Director, NVP, on matters related to the 
program's responsibilities.
    Topics to be discussed at the meeting include: Pandemic Influenza 
and the Pandemic Influenza Response and Preparedness Plan, the NVAC 
Influenza Working Group's preliminary assessment of domestic influenza 
issues/needs, and the Institute of Medicine's (IOM) vaccine safety 
review. Updates will be given on the NVAC Working Group on Public 
Participation and from the NVAC Vaccine Safety and Communications 
Subcommittee, the NVAC Futures Vaccines Subcommittee, and the NVAC 
Immunization Coverage Subcommittee. A tentative agenda will be made 
available May 20 for review on the NVPO Web site, http://www.dhhs.gov/nvpo.
    Public attendance at the meeting is limited to space available. 
Individuals must provide a photo ID for entry into the Humphrey 
Building. Individuals who plan to attend and need special assistance, 
such as sign language interpretation or other reasonable 
accommodations, should notify the designated contact person. Members of 
the public will have the opportunity to provide comments at the 
meeting. Public comment will be limited to five minutes per speaker. 
Any members of the public who wish to have printed material distributed 
to NVAC members should submit materials to the Executive Secretary, 
NVAC, whose contact information is listed above prior to close of 
business May 25, 2004. Preregistration is required for both public 
attendance and comment. Any individual who wishes to attend the meeting 
and/or participate in the public comment session should email 
[email protected].

    Dated: May 10, 2004.
Bruce G. Gellin,
Director, National Vaccine Program Office, and Executive Secretary, 
National Vaccine Advisory Committee.
[FR Doc. 04-11033 Filed 5-14-04; 8:45 am]
BILLING CODE 4150-28-P